A Look At Kemper (KMPR) Valuation After A Difficult Year For Shareholders
Kemper Corp KMPR | 32.50 32.50 | +1.03% 0.00% Post |
Assessing Kemper after a tough year for returns
Kemper (KMPR) has drawn attention after a difficult run for shareholders, with the stock showing negative returns over the past month, past 3 months, year to date and over the past year.
At a last close of US$32.34, the Chicago based insurer, which reports annual revenue of US$4,789.7m and net income of US$143.3m, now carries a value score of 4 in this dataset.
For Kemper, the recent 16% 30 day share price decline sits on top of a much steeper 1 year total shareholder return loss of 49%, suggesting sentiment has weakened rather than improved despite its current valuation score.
If this kind of pullback has you looking further afield in financials and beyond, it could be a good moment to broaden your search with 23 top founder-led companies.
So with Kemper trading at US$32.34 against a value score of 4 and a sizeable discount to some estimates, are you looking at an undervalued insurer, or a stock where the market has already priced in what comes next?
Most Popular Narrative: 7.6% Undervalued
Compared with a narrative fair value of $35.00, Kemper at $32.34 screens as slightly cheaper, and the story behind that gap leans heavily on future cash flows discounted at 7.47%.
The company's strong capital position, record operating cash flow, and newly expanded $550 million share repurchase authorization indicate significant balance sheet flexibility, which may drive higher per share earnings and support stock price appreciation.
Curious what sort of revenue path, margin profile, and earnings multiple need to line up for that $35.00 fair value to make sense? The most followed narrative lays out a detailed glide path for growth, profitability, and valuation, built line by line from explicit analyst style assumptions, but it only really clicks when you see how those pieces interact over time.
Result: Fair Value of $35.00 (UNDERVALUED)
However, that story can break if catastrophe losses and reserve issues keep pressure on underwriting margins, or if insurtech rivals force higher customer acquisition costs.
Next Steps
Given the mixed tone around Kemper so far, it makes sense to move quickly and review the full picture for yourself, including 3 key rewards and 1 important warning sign.
Looking for more investment ideas?
If Kemper is only one piece of your watchlist, do not stall here. Use the Simply Wall Street Screener to uncover fresh opportunities that fit your goals.
- Hunt for quality at a better price with our list of 56 high quality undervalued stocks that currently stand out on both fundamentals and valuation checks.
- Prioritise resilience by scanning 80 resilient stocks with low risk scores and focus on companies that score well on balance sheet strength and business risk factors.
- Get ahead of the crowd by checking a screener containing 24 high quality undiscovered gems before they attract wider attention and potentially reshape your opportunity set.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
